Where does Nogra Pharma Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nogra Pharma Limited ranks #7,746 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nogra Pharma Limited hold?

Nogra Pharma Limited holds 42 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Nogra Pharma Limited's Innovation Score?

Nogra Pharma Limited has an Innovation Score of 34.8 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nogra Pharma Limited focus on?

Nogra Pharma Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 41 patents, ranking #446 of 6,058 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Nogra Pharma Limited's patent grant rate increasing or decreasing?

Nogra Pharma Limited's recent grant velocity is -63% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Nogra Pharma Limited's patents?

Nogra Pharma Limited's patents average 11.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nogra Pharma Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nogra Pharma Limited

USPTO PatentsView assignee record - 42 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nogra ranks #7,746 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 12 technology areas.

#7,746
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.8/100): 11.3
avg claims per patent: -63%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7746 · Foreign Corporation #7,746 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 42 grants
UPPER-Q #7,746/49,997
PHOTO-FINISH NantCell
CPC-FOCUS A61P · 12 areas
INNOV-THIN 34.8/100
CLAIMS-PAR 11.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -63% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: NantCell, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nogra’s 34.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (37%) Velocity 2.8 pts (8%) Breadth 12.2 pts (35%) Claim depth 6.8 pts (20%)

Qualcomm Incorporated · highest

85
Sunland Information… · near

35
Videx · near

35
Consort Medical · near

35
Nogra Pharma · this assignee

35
Philogen S P A · near

35
3D Lighting… · lowest

7

What this shows Nogra's Innovation Score is 34.8/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nogra?

Each dot is one of Nogra’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nogra’s own 11.3 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nogra vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nogra's grants concentrate

Nogra Pharma Limited is a focused PatentsView assignee: 12 CPC subclasses with 97.6% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (9 grants) versus a trough of 1 in 2022. By volume, Nogra sits between Nippon Steel & Sumikin Stainless Steel Corporation and Orthofix S.R.L..

Nogra's three-year grant acceleration

Nogra Pharma Limited shows 5 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nippon Steel & Su…

42
Nantcell

42
Neutrik

42
Nextivity

42
Northwestern Poly…

42
Osaka Prefecture…

42
Orbotech

42
Orthofix S R L

42
Nogra Pharma ◀

42

What this shows Nogra holds 42 patents at rank #7,746, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nogra

By rank, the assignees closest to #7,746 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Nogra's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nogra, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Nogra ranks #446 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Philogen S.P.A. 35 Consort Medical PLC 35 Sunland Information Technology Co., Ltd. 35 Videx, Inc. 35

Nogra's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Nogra Pharma Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	7.1%
2016	7	16.7%
2017	5	11.9%
2018	9	21.4%
2019	6	14.3%
2020	3	7.1%
2021	3	7.1%
2022	1	2.4%
2023	1	2.4%
2024	3	7.1%
2025partial year	1	2.4%

Which technologies does Nogra Pharma Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 41

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 35

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 21

C07C - Acyclic OR Carbocyclic Compounds 16

C07D - Heterocyclic Compounds 9

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07K - Peptides 1

A23C - Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nogra Pharma Limited's patent record in context - here's where to go next.

Nogra Pharma Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 97.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #7,746 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nogra Pharma Limited against Nippon Steel & Sumikin Stainless Steel Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.